A proposed evaluation algorithm for the heterogeneity of the baseline risk within patient populations of clinical trial

John P A Ioannidis; Joseph Lau

doi:10.1016/s0197-2456(98)80170-0

Related publications

Article2001

Predictive modeling and heterogeneity of baseline risk in meta-analysis of individual patient data

Thomas A Trikalinos, John P A Ioannidis

Article2019

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

Judith S. Hochman, Harmony R. Reynolds, Sripal Bangalore, Sean M. O’Brien, Karen P. Alexander, Roxy Senior, William E. Boden, Gregg W. Stone, Shaun G. Goodman, Renato D. Lópes, José López‐Sendón, Harvey D. White, Aldo Maggioni, Leslee J. Shaw, James K. Min, Michael H. Picard, Daniel S. Berman, Bernard Chaitman, Daniel B. Mark, John A. Spertus, Derek D. Cyr, Balram Bhargava, Witold Rużyłło, Gurpreet Singh Wander, Alexander Chernyavskiy, Yves Rosenberg, David J. Maron

Article2024

Clinical trial evaluation: the EDOSURE clinical trial program

Michael Griffin, Professor Gregory Lip

Article2021

P-80 Sorafenib in extended patient populations in real-world clinical practice: Baseline characteristics from OPTIMIS and GIDEON

Markus Peck‐Radosavljevic, Riccardo Lencioni, Kirhan Özgürdal, Masatoshi Kudo

Article2008

Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation

Nikolaos A. Patsopoulos, Εvangelos Εvangelou, John P A Ioannidis